Intensive insulin first, then fewer drugs: a new strategy for type 2 diabetes?
NCT ID NCT03958591
First seen May 17, 2026 · Last updated Jun 23, 2026 · Updated 6 times
Summary
This study tested whether starting with a short course of intensive insulin therapy, followed by a simpler combination of drugs, could help people with poorly controlled type 2 diabetes eventually use fewer medications. 274 participants were randomly assigned to different treatment paths. The goal was to see if more patients could control their blood sugar with just two oral drugs instead of multiple injections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Department of endocrinology, FAH-SYSU
Guangzhou, Guangdong, 510080, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
insulin, metformin, vildagliptin
What this could lead to
If successful, this approach could help many people with type 2 diabetes manage their blood sugar with fewer daily injections or pills.
What could go wrong
This is a completed Phase 4 trial, but results may not apply to all diabetes patients. The simplification strategy may not work for everyone and requires careful monitoring.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.